Au, D., Lee, E. K., Popoola, T. O., Parker, W. P., Onge, J. M. S., & Ellis, S. D. (2021). Factors associated with utilization of neoadjuvant chemotherapy in charlson comorbidity zero non-metastatic muscle-invasive bladder cancer patients. International Brazilian Journal of Urology, 47(4), 803-818. https://doi.org/10.1590/s1677-5538.ibju.2020.0594
Chicago-Zitierstil (17. Ausg.)Au, Daniel, Eugene K. Lee, Taiye O. Popoola, William P. Parker, Jarron M. Saint Onge, und Shellie D. Ellis. "Factors Associated with Utilization of Neoadjuvant Chemotherapy in Charlson Comorbidity Zero Non-metastatic Muscle-invasive Bladder Cancer Patients." International Brazilian Journal of Urology 47, no. 4 (2021): 803-818. https://doi.org/10.1590/s1677-5538.ibju.2020.0594.
MLA-Zitierstil (9. Ausg.)Au, Daniel, et al. "Factors Associated with Utilization of Neoadjuvant Chemotherapy in Charlson Comorbidity Zero Non-metastatic Muscle-invasive Bladder Cancer Patients." International Brazilian Journal of Urology, vol. 47, no. 4, 2021, pp. 803-818, https://doi.org/10.1590/s1677-5538.ibju.2020.0594.